Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia
Obes Res
.
2003 Feb;11(2):311-2.
doi: 10.1038/oby.2003.46.
Authors
Judith Korner
,
Janet Lo
,
Pamela U Freda
,
Sharon L Wardlaw
PMID:
12582229
DOI:
10.1038/oby.2003.46
No abstract available
Publication types
Letter
MeSH terms
Anti-Obesity Agents
Cabergoline
Ergolines / adverse effects*
Female
Humans
Hyperprolactinemia / drug therapy*
Male
Weight Loss*
Substances
Anti-Obesity Agents
Ergolines
Cabergoline